Managing risks and harms associated with the use of anabolic steroids: a qualitative study
- PMID: 40722023
- PMCID: PMC12302693
- DOI: 10.1186/s12954-025-01269-x
Managing risks and harms associated with the use of anabolic steroids: a qualitative study
Abstract
Background: People using anabolic steroids adopt different strategies to manage risks and harms associated with the use of these substances. We investigated how users learn, develop and incorporate risk-management strategies, as well as the events triggering changes in their health-related behaviour.
Methods: Twenty semi-structured interviews were conducted with anabolic steroid users living in the UK to discuss their risk-management strategies (19 males, 1 female; median age = 35.5 years; median time of anabolic steroid use = 9 years). Online interviews were transcribed verbatim and qualitative data was analysed via iterative categorisation.
Results: The use of risk-management strategies was characterised as a continuous cycle of identification, prevention and control of risks and harms. Preventative strategies were more commonly adopted after many years of anabolic steroid use. Changes in life circumstances and adverse health conditions were described as common triggers for changes in behaviour, including the cessation of anabolic steroid use.
Conclusion: Our findings can inform interventions aimed at increasing awareness and promoting healthier behaviours among people who use anabolic steroids. Further research is needed to evaluate the effectiveness and safety of the risk-management strategies employed by this population.
Keywords: Anabolic steroids; Harm-reduction; Human-enhancement drugs.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical approval was obtained from King’s College London Psychiatry, Nursing and Midwifery Research Ethics Subcommittee (Reference HR-20/21-22034). Participants’ consent was warranted prior to the interviews. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study.Swiss Med Wkly. 2025 Feb 6;155:4225. doi: 10.57187/s.4225. Swiss Med Wkly. 2025. PMID: 39977451
-
Harm reduction measures in a recreational gym user with anabolic androgenic steroid dependence: a case report in the context of current best clinical practice.Harm Reduct J. 2025 Aug 21;22(1):144. doi: 10.1186/s12954-025-01294-w. Harm Reduct J. 2025. PMID: 40841640 Free PMC article.
-
Anabolic steroids for treating pressure ulcers.Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD011375. doi: 10.1002/14651858.CD011375.pub2. Cochrane Database Syst Rev. 2017. PMID: 28631809 Free PMC article.
-
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159. Health Soc Care Deliv Res. 2025. PMID: 40548558
-
Group-based interventions to reduce gambling involvement among male football fans: a synopsis of findings from a feasibility study.Public Health Res (Southampt). 2025 Jul;13(6):1-24. doi: 10.3310/SWWP9393. Public Health Res (Southampt). 2025. PMID: 40690427
References
-
- Nieschlag E, Vorona E. Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015;173(2):R47–58. - PubMed
-
- Smit D, Buijs M, de Hon O, den Heijer M, de Ronde W. Positive and negative side effects of androgen abuse. The HAARLEM study: A one-year prospective cohort study in 100 men. Scand J Med Sci Sports. 2021;31(2):427–38. - PubMed
-
- D’andrea A, Radmilovic · Juri, Caselli S, Carbone A, Scarafile R, Sperlongano S et al. Left atrial myocardial dysfunction after chronic abuse of anabolic androgenic steroids: a speckle tracking echocardiography analysis. Int J Cardiovasc Imaging. 2018;34:1549–59. - PubMed
-
- Scarth M, Havnes I, Marie L, Mcveigh J, Van Hout M, Westlye LT, et al. Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway. Drug Alcohol Depend. 2022;231:109275. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical